Improved anatomical reproducibility in quantitative lower‐limb muscle MRI
暂无分享,去创建一个
Arne Fischmann | Tarek Yousry | Michael G Hanna | Mary M Reilly | T. Yousry | J. Thornton | M. Reilly | M. Hanna | A. Fischmann | J. Morrow | C. Sinclair | John S Thornton | Jasper M Morrow | Christopher D J Sinclair
[1] D. Felsenberg,et al. Heterogeneous atrophy occurs within individual lower limb muscles during 60 days of bed rest. , 2012, Journal of applied physiology.
[2] Susana Quijano-Roy,et al. Whole body muscle MRI protocol: Pattern recognition in early onset NM disorders , 2012, Neuromuscular Disorders.
[3] Volker Straub,et al. Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: Consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris, France , 2012, Neuromuscular Disorders.
[4] Volker Straub,et al. TREAT-NMD workshop: Pattern recognition in genetic muscle diseases using muscle MRI 25–26 February 2011, Rome, Italy , 2012, Neuromuscular Disorders.
[5] T. Yousry,et al. 1700 MRI quantification of lower limb muscle fatty atrophy: a potential outcome measure in chronic neuromuscular diseases , 2012, Journal of Neurology Neurosurgery & Psychiatry.
[6] R. Finkel,et al. Thigh Muscle Volume Measured by Magnetic Resonance Imaging Is Stable Over a 6-Month Interval in Spinal Muscular Atrophy , 2011, Journal of Child Neurology.
[7] K. Scheffler,et al. Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy , 2011, Journal of Neurology.
[8] P. Bini,et al. Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response , 2010, Journal of Inherited Metabolic Disease.
[9] G. Nicholson,et al. Correlation between muscle atrophy on MRI and manual strength testing in hereditary neuropathies , 2010, Journal of Clinical Neuroscience.
[10] M. Geschwind. Are you Related to “the Geschwind?” , 2010, Neuropsychology Review.
[11] M. Maas,et al. Reliability of in vivo determination of forearm muscle volume using 3.0 T magnetic resonance imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[12] Zhaohua Ding,et al. Repeatability of DTI‐based skeletal muscle fiber tracking , 2010, NMR in biomedicine.
[13] X. Golay,et al. P86 Inter-scan reproducibility of quantitative neuromuscular MRI , 2010, Neuromuscular Disorders.
[14] M. Wattjes,et al. Whole‐body high‐field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita , 2010, Acta neurologica Scandinavica.
[15] A. Pestronk,et al. A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy , 2008, Annals of neurology.
[16] Brian C Clark,et al. Reliability of techniques to assess human neuromuscular function in vivo. , 2007, Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology.
[17] H. Schild,et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 , 2006, Journal of Neurology.
[18] D. Downham,et al. Assessment of contractile and noncontractile components in human skeletal muscle by magnetic resonance imaging , 2002, Muscle & nerve.
[19] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[20] Klaus Bohndorf,et al. Muscle cross-section measurement by magnetic resonance imaging , 2004, European Journal of Applied Physiology and Occupational Physiology.
[21] H. Schild,et al. Wattjes Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 A whole body highfield MRI study , 2022 .